The RDA for protein is 0.8 g per kg of body weight per day. That number is widely misunderstood. It was set in 1968 as the lowest intake at which most healthy adults remain in nitrogen balance: meaning, the floor below which deficiency starts to show up in nitrogen excretion studies. It is not the optimal intake, and it does not adjust for age, training status, or healthspan goals. For a 70 kg sedentary 30-year-old, the RDA is 56 g/day. For a 70 kg trained 30-year-old, the protein-and-hypertrophy literature pushes that target to 112-140 g/day. For a 70 kg 70-year-old fighting sarcopenia, the realistic target is closer to 90-110 g/day.
This article walks the age-adjusted curve, where it inflects, and what the per-meal numbers should be at each life stage.
What the per-age data actually shows
Phillips 2016 ("Protein requirements beyond the RDA") is the cleanest synthesis of the modern protein-requirements literature ( Phillips et al. 2016 ). Three claims worth pulling out:
- The RDA underestimates optimal intake for healthy adults at every life stage where measurable functional outcomes (lean mass retention, strength, recovery) are tracked. The RDA was designed for nitrogen balance, not for functional optimization.
- Per-meal distribution becomes more important than daily total once daily total clears 1.2 g/kg/day in older adults and 1.6 g/kg/day in younger adults.
- Per-meal leucine threshold is the practical operationalization of "distribution matters." Below ~2.5 g leucine per meal, MPS response is suboptimal regardless of meal frequency.
Morton et al. 2017 meta-analysis of 49 trials (n=1863 trained adults) found total daily protein up to 1.62 g/kg/day produced additional hypertrophy benefit; above that threshold, additional protein produced no further benefit ( Morton et al. 2017, n=1863 ). The plateau was younger-skewed (median age in the meta was around 30) and almost certainly understates the per-meal floor that older adults need.
Levine et al. 2014 (NHANES, n=6381) is the wildcard ( Levine et al. 2014, n=6381 ). In 50-65-year-olds, high animal-protein intake (≥20% of calories from animal protein) was associated with 4x cancer mortality and 75% higher all-cause mortality versus low intake (<10% animal protein). Above age 65, the same intake was associated with 60% lower cancer mortality and 28% lower all-cause mortality. The proposed mechanism: IGF-1 elevation: is consistent with rapamycin and caloric-restriction work showing growth and longevity as partial trade-offs.
The Levine signal is observational. It is also internally consistent (the IGF-1 path explains both directions). It is the cleanest argument for treating protein-source choice differently in the 50-65 window than in the under-50 or over-65 windows.
The age-adjusted target table
Protein targets that incorporate the trial evidence and the Levine signal:
Pediatric (under 18): 0.95-1.4 g/kg/day depending on growth velocity. Per-meal threshold is less critical because total daily distribution is naturally elevated by frequent eating. Source quality matters less because growth-state MPS is hyper-responsive.
Young adult, sedentary (18-35): 1.0-1.2 g/kg/day. The RDA's 0.8 is a deficiency floor; 1.0-1.2 is the optimization range that supports lean-mass maintenance and recovery from incidental physical activity. Source choice matters less at this intake range.
Young adult, training (18-35): 1.4-1.8 g/kg/day across 4 meals at 30-40 g each. Hit per-meal leucine threshold reliably. Source choice matters most at lower per-meal doses; whey > soy > pea-rice > rice, gram for gram. Above 1.6 g/kg/day daily total, source choice impact decays.
Adult, mid-life sedentary (35-50): 1.0-1.4 g/kg/day. The middle target. Mixed sources are defensible. Per-meal distribution starts mattering more as anabolic resistance begins around age 40 in epidemiological cohorts.
Adult, mid-life training (35-50): 1.4-1.8 g/kg/day, same per-meal logic as the younger trained cohort. Anabolic resistance is real but modest in this range; daily total is still the dominant variable.
Mid-life inflection (50-65): 1.2-1.6 g/kg/day. This is the Levine 2014 window. Total intake target stays on the modern protein-and-healthspan curve, but the source split is debatable. If sedentary or low-training, lean toward plant or mixed sources; the IGF-1 signal is theoretically stronger than the muscle-mass signal. If actively training and resisting sarcopenia preemptively, the muscle-mass signal dominates again.
Older adult (65+): 1.2-1.6 g/kg/day with a strict 30-40 g per-meal floor. Anabolic resistance compounds: the same dose produces a smaller MPS response than in younger muscle. The PROT-AGE European consensus group recommended ≥1.0-1.2 g/kg/day for healthy older adults and ≥1.2-1.5 g/kg/day for those with acute or chronic disease. The Levine 2014 signal flips: animal protein and elevated IGF-1 are protective in this group via the muscle-mass-equals-mortality-protection path.
Frailty / acute illness (any age): 1.5-2.0 g/kg/day under clinician supervision. The catabolic stress of acute illness or hospitalization shifts the target up. Per-meal leucine threshold becomes critical because appetite is suppressed.
The pattern: the daily total target is more uniform than people expect (1.2-1.6 g/kg/day across most of adult life). The per-meal distribution and source-choice questions are where the age-stratification really lives.
Anabolic resistance, mechanistically
Anabolic resistance is the single most important concept in age-adjusted protein. It is the observed phenomenon that the same dose of leucine produces a smaller and slower MPS response in older muscle than in younger muscle. The thresholds shift up:
- Where 25 g of high-quality protein (containing ~2.5 g leucine) reliably triggers MPS in a 30-year-old, the equivalent stimulus in a 70-year-old is closer to 40 g (containing ~3.0-3.5 g leucine).
- Where younger muscle responds to the leucine signal within 1-2 hours, older muscle's MPS response is delayed and blunted.
The proposed mechanisms include reduced mTOR signaling sensitivity, decreased post-meal blood flow to muscle (which reduces amino-acid delivery), and reduced satellite cell pool. The clinical translation is straightforward: hit higher per-meal protein doses, lean toward higher-quality protein sources, distribute across 3-4 meals rather than concentrate at one, and combine protein meals with light resistance training when possible (which acutely increases muscle blood flow and partially restores anabolic sensitivity).
For the 70-year-old aiming at 1.4 g/kg/day on a 70 kg frame, that's 98 g/day. Distributed across 3 meals at 30-35 g each plus a 5-10 g buffer. From food, this is a 100-120 g serving of beef, fish, or poultry per meal. From whey, that's a 30-35 g protein scoop. From plant sources without leucine fortification, this gets impractical: 100 g of beans plus 100 g of nuts plus a tofu side per meal.
Distribution beats total above the leucine threshold
Phillips 2016 makes the strongest case for distribution-over-total once daily total clears the saturating range. The mechanistic argument: MPS is an acute event triggered by leucine reaching a threshold concentration. Two meals of 60 g each produce two MPS pulses; four meals of 30 g each produce four MPS pulses. The integrated MPS over 24 hours is higher with the four-meal pattern, even at matched daily total.
The practical implication for older adults is that breakfast is the under-protein meal in most diets. A typical 70-year-old's breakfast is around 8-15 g protein (oatmeal with milk, toast with eggs). That fails the per-meal leucine threshold. Adding a scoop of whey or a 100 g Greek yogurt with breakfast routinely turns one wasted meal into one MPS-triggering meal.
The 30-40 g per-meal floor is the operationalization of "distribution matters." Below that, the meal is in the noise. Above that, the meal is doing work.
What this isn't
This is not a kidney-disease protein guide. Adults with chronic kidney disease, or those at risk of it, should defer to clinician guidance; the protein-and-eGFR conversation is a different framework.
It is not a high-protein-causes-cancer panic. The Levine 2014 cancer-mortality signal is observational, age-stratified, and confined to a specific 50-65 window. The signal does not survive the over-65 analysis, and it conflicts with the Morton-Phillips operational evidence that protein-up improves functional outcomes across most life stages.
It is not a generic "more protein is always better." Above 1.6-1.8 g/kg/day, the marginal benefit on hypertrophy plateaus. Above 2.0 g/kg/day, the marginal benefit on any functional outcome is poorly characterized and the macronutrient displacement (protein replaces carbs or fat) starts mattering more than additional protein-quality returns.
The decision tree above is the cleanest version of "depends on age and goal" anyone has produced from the trial evidence. The honest summary: 1.2-1.6 g/kg/day across most of adult life, distributed across 3-4 meals, with stricter per-meal floors and source-quality attention as you cross 65.
